These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6740558)

  • 1. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Apr; 51(2):266-8. PubMed ID: 6740558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III.
    Lijnen HR; van Hoef B; Collen D
    Thromb Haemost; 1983 Aug; 50(2):560-2. PubMed ID: 6415849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
    Tollefsen DM; Pestka CA
    J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The inhibitory effects of histidine-rich glycoprotein on the anticoagulant activity of heparin].
    Niwa M
    Nihon Ketsueki Gakkai Zasshi; 1988 Nov; 51(7):1130-7. PubMed ID: 3223216
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of immobilised unfractionated and LMW heparins with proteins in whole human plasma.
    Zammit A; Pepper DS; Dawes J
    Thromb Haemost; 1993 Dec; 70(6):951-8. PubMed ID: 8165617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidine-rich glycoprotein plus zinc to neutralize heparin.
    Fu CL; Horn MK
    J Lab Clin Med; 2002 Apr; 139(4):211-7. PubMed ID: 12024108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time.
    al Dieri R; Alban S; Béguin S; Hemker HC
    J Thromb Haemost; 2004 Aug; 2(8):1395-401. PubMed ID: 15304046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma.
    Lijnen HR; Hoylaerts M; Collen D
    J Biol Chem; 1983 Mar; 258(6):3803-8. PubMed ID: 6833231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant effects of heparin in neonatal plasma.
    Schmidt B; Ofosu FA; Mitchell L; Brooker LA; Andrew M
    Pediatr Res; 1989 Apr; 25(4):405-8. PubMed ID: 2726317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin.
    Stief TW
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):633-7. PubMed ID: 17102649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation protein function: the influence of acetaldehyde-modified heparin on thrombin activity.
    Brecher AS; Fu Q
    J Investig Med; 1999 Jan; 47(1):76-80. PubMed ID: 10071484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma.
    Bhargava AS; Heinick J; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(6):993-6. PubMed ID: 7191280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative inhibition of extrinsic and intrinsic thrombin generation by standard heparin, a low molecular weight heparin and the synthetic ATIII-binding pentasaccharide.
    Lormeau JC; Herault JP
    Thromb Haemost; 1993 Feb; 69(2):152-6, 176. PubMed ID: 8384381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.